T. Rowe Price Associates’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $36.9M | Buy |
|
|||||
|
2025
Q2 | $31.6M | Sell |
|
|||||
|
2025
Q1 | $56M | Sell |
|
|||||
|
2024
Q4 | $64.5M | Buy |
|
|||||
|
2024
Q3 | $67.2M | Sell |
|
|||||
|
2024
Q2 | $96M | Buy |
|
|||||
|
2024
Q1 | $158M | Sell |
|
|||||
|
2023
Q4 | $201M | Buy |
|
|||||
|
2023
Q3 | $131M | Buy |
|
|||||
|
2023
Q2 | $145M | Buy |
|
|||||
|
2023
Q1 | $68.4M | Buy |
|
|||||
|
2022
Q4 | $76.1M | Buy |
|
|||||
|
2022
Q3 | $54.6M | Buy |
|
|||||
|
2022
Q2 | $11.7M | Sell |
|
|||||
|
2022
Q1 | $10.3M | Sell |
|
|||||
|
2021
Q4 | $13M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Sell |
|
|||||
|
2021
Q2 | $14.3M | Sell |
|
|||||
|
2021
Q1 | $16.5M | Buy |
|